Expand MRKR Menu
MRKR MENU

MRKR Stock Summary and Trading Ideas (Marker Therapeutics | NASDAQ:MRKR)

Charts for Today's Stock Price and Implied Volatility in Marker Therapeutics

22-Dec-2025

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Marker Therapeutics (MRKR) Frequently Asked Questions

What does Marker Therapeutics do?

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

What symbol and exchange does Marker Therapeutics shares trade?

Marker Therapeutics trades on the NASDAQ stock market under the symbol MRKR.

What is Marker Therapeutics stock price doing today?

As of December 22, 2025, MRKR stock price climbed to $1.42 with 440,382 million shares trading.

What is Marker Therapeutics's Beta?

MRKR has a beta of 1.49, meaning it tends to be more sensitive to market movements. MRKR has a correlation of 0.11 to the broad based SPY ETF.

How much is Marker Therapeutics worth?

MRKR has a market cap of $23.68 million. This is considered a Sub-Micro Cap stock.

How much money does Marker Therapeutics make?

Last quarter Marker Therapeutics reported $1 million in Revenue and -$.12 earnings per share. This beat revenue expectation by $510,000 and exceeded earnings estimates by $.28.

What is the highest and lowest price Marker Therapeutics traded in the last 3 year period?

In the last 3 years, MRKR traded as high as $9.68 and as low as $.67.

What are the top ETFs holding Marker Therapeutics?

The top ETF exchange traded funds that MRKR belongs to (by Net Assets): VTI, VXF.

Is Marker Therapeutics (MRKR) a good investment?

MRKR has underperformed the market in the last year with a price return of -62.6% while the SPY ETF gained +17.1%. However, in the short term, MRKR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +57.8% vs +3.0% return in SPY. But in the last 2 weeks, MRKR shares have been beat by the market, returning 0.0% compared to an SPY return of +0.5%.

What are the support and resistance levels for Marker Therapeutics (MRKR)?

MRKR support price is $1.21 and resistance is $1.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRKR shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes